Epidermal growth factor receptor expression is predictive of poor prognosis in feline cutaneous squamous cell carcinoma

Journal of Feline Medicine and Surgery

Volumn 12, Issue 10, 2010, Pages 760-768

  Sabattini, Silvia ^a   Marconato, Laura ^b   Zoff, Aurora ^a   Morini, Maria ^a   Scarpa, Filippo ^a   Capitani, Ombretta ^a   Bettini, Giuliano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Animal Oncology and Imaging Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CAT DISEASES; CATS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

FELIDAE;

EID: 77956877035     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2010.04.010     Document Type: Article

References (19)

1. Miller M.A., Nelson S.L., Turk J.R., et al. Cutaneous neoplasia in 240 cats. Vet Pathol 1991, 28:389-395.
2. Ogilvie G.K., Moore A.S. Feline oncology. A comprehensive guide to compassionate care 2001, Veterinary Learning Systems, Trenton.
3. Goldschmidt M.H., Shofer F.S. Squamous cell carcinoma. Skin tumors of the dog and the cat. 1992, 37-50. Pergamon Press, New York. 1st edn.
4. Favrot C., Welle M., Heimann M., Godson D.L., Guscetti F. Clinical, histologic and immunohistochemical analyses of feline squamous cell carcinoma in situ. Vet Pathol 2009, 46:25-33.
5. Ongkeko W.M., Altuna X., Weisman R.A., Wang-Rodriguez J. Expression of protein tyrosine kinases in head and neck squamous cell carcinomas. Am J Clin Pathol 2005, 124:71-76.
6. Holden J.A., Willmore-Payne C., Layfield L.J. Tyrosine kinase activating mutations in human malignancies: implications for diagnostic pathology. Exp Mol Pathol 2008, 85:68-75.
7. Nelson E.G., Grandis J.R. Aberrant kinase signalling: lessons from head and neck cancer. Future Oncol 2007, 3:353-361.
8. Harari P.M. Epidermal growth factor receptor inhibition strategies in oncology. Endocr Relat Cancer 2009, 11:689-708.
9. Looper J.S., Malarkey D.E., Ruslander D., Proulx D., Thrall D.E. Epidermal growth factor receptor expression in feline oral squamous cell carcinomas. Vet Comp Oncol 2006, 4:33-40.
10. Shiomitsu K., Johnson C.L., Malarkey D.E., Pruitt A.F., Thrall D.E. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumors. Vet Comp Oncol 2009, 7:106-114.
11. Grandis J.R., Melhem M.F., Barnes E.L., Tweardy D.J. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 1996, 78:1284-1292.
12. Ang K.K., Berkey B.A., Tu X., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002, 62:7350-7356.
13. Piyathilake C.J., Frost A.R., Manne U., et al. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin Cancer Res 2002, 8:734-744.
14. Adams E.J., Green J.A., Clark A.H., Youngson J.H. Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol 1999, 52:75-77.
15. Damjanov I., Mildner B., Knowles B. Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab Invest 1986, 55:588-592.
16. Srinivasan R., Poulsom R., Hurst H., Gullick W. Expression on the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumor types. J Pathol 1998, 185:236-245.
17. Sheik Ali M.A., Gunduz M., Nagatsuka H., et al. Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. Cancer Sci 2008, 99:1589-1594.
18. Lurje G., Lenz H.J. EGFR signaling and drug discovery. Oncology 2010, 77:400-410.
19. Parra H.S., Cavina R., Latteri F., et al. Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer. Br J Cancer 2004, 91:208-212.